Table 1.
Fragment (aa start-end) | Primer (5′-3′ sequence) |
EIA titerb |
||
---|---|---|---|---|
Forward | Reverse | MAb 2B11 | MAb 1E11 | |
N1 (31-372) | N1for (CACCAAAGATGCAATGGAAAGAAC) | Bflrev (TTATGCTTTTTTCGTATCTACTTTAATAT) | 640 | >640 |
N2 (61-372) | N2for (CACCAATGTATCGTCTGTTGATG) | Bflrev (TTATGCTTTTTTCGTATCTACTTTAATAT) | 320 | >640 |
N3 (93-372) | N3for (CACCCCACAGCTTATTTCAACG) | Bflrev (TTATGCTTTTTTCGTATCTACTTTAATAT) | 320 | >640 |
N4 (122-372) | N4for (CACCGCAAAGGATAAAGCAACT) | Bflrev (TTATGCTTTTTTCGTATCTACTTTAATAT) | 160 | >640 |
N5 (152-372) | N5for (CACCGACCTGAAGAAATTCCG) | Bflrev (TTATGCTTTTTTCGTATCTACTTTAATAT) | – | >640 |
C1 (205-258) | C1for (CACCATTATTATCGGTTCATC) | C1rev (CTTGCGTAATACGATTCCAG) | – | – |
C2 (251-324) | C2for (CACCACAGCTGGAATCGTATTA) | C2rev (AAGTAAAGAATTGTATTTTGATCC) | – | – |
C3 (314-372) | C3for (CACCTACACAATGGGATCA) | C3rev (TGCTTTTTTCGTATCTACTAC) | – | >640 |
Amino acid (aa) numbering according to Granum et al. (14), without signal peptide. Gray shading in the forward primer sequences indicates additional nucleotides needed for directional cloning approach.
Reciprocal dilution. –, Negative at the lowest dilution tested (1:5).